☰

Maira M. Pires, Ph.D. - Publications

Affiliations: 
2013 Biochemistry and Molecular Biophysics Columbia University, New York, NY 
Area:
Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Lau YK, Du X, Rayannavar V, Hopkins B, Shaw J, Bessler E, Thomas T, Pires MM, Keniry M, Parsons RE, Cremers S, Szabolcs M, Maurer MA. Metformin and erlotinib synergize to inhibit basal breast cancer. Oncotarget. 5: 10503-17. PMID 25361177 DOI: 10.18632/Oncotarget.2391  0.643
2014 Pires MM, Aaronson SA. Brachyury: a new player in promoting breast cancer aggressiveness. Journal of the National Cancer Institute. 106. PMID 24815862 DOI: 10.1093/Jnci/Dju094  0.519
2014 Marshall N, Sanchez F, Llobet D, Barrueco RR, Castro V, Kotlia D, Pires M, Villagrasa P, Putcha P, Parsons R, Pe'er D, Silva J. Abstract 432: BIN3 is a novel 8p21 tumor suppressor gene that regulates the attachment checkpoint in epithelial cells Cancer Research. 74: 432-432. DOI: 10.1158/1538-7445.Am2014-432  0.642
2013 Keniry M, Pires MM, Mense S, Lefebvre C, Gan B, Justiano K, Lau YK, Hopkins B, Hodakoski C, Koujak S, Toole J, Fenton F, Calahan A, Califano A, DePinho RA, et al. Survival factor NFIL3 restricts FOXO-induced gene expression in cancer. Genes & Development. 27: 916-27. PMID 23630076 DOI: 10.1101/Gad.214049.113  0.571
2013 Pires MM, Hopkins BD, Saal LH, Parsons RE. Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells. Cancer Biology & Therapy. 14: 246-53. PMID 23291982 DOI: 10.4161/Cbt.23297  0.68
2010 Lau Y, Pires M, Shaw J, Campbell J, Parsons R, Maurer M. Abstract PD03-05: A Novel Combination Therapy for Triple Negative Breast Cancer: Erlotinib and Metformin Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd03-05  0.674
2008 Saal LH, Gruvberger-Saal SK, Persson C, Lövgren K, Jumppanen M, Staaf J, Jönsson G, Pires MM, Maurer M, Holm K, Koujak S, Subramaniyam S, Vallon-Christersson J, Olsson H, Su T, et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nature Genetics. 40: 102-7. PMID 18066063 DOI: 10.1038/Ng.2007.39  0.676
Show low-probability matches.